Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Brief Psychotic Disorder Clinical Trial

Official title: Effectiveness of the Individualized Metacognitive Training (EMC+) in People With Psychosis of Brief Evolution

Status Completed

Clinical Trial Summary

The main aim of the study is to evaluate the effectiveness of Individualized Meta-Cognitive Training (EMC +), in people with psychosis of brief evolution on symptoms, especially on positive symptoms. Secondary aims would be to assess the effect of EMC+ in metacognition, psychosocial and neuropsychological functioning, and to assess the maintenance of program effects on 6 months.

Clinical Trial Description

This is a randomized clinical trial in which some patients receive the EMC+ and others treatment as usual.The evaluator will be blind to the group to which the patients belong. The sample for the overall project will be a total of 70 people with a diagnosis of psychotic spectrum, less than 5 years of experience and with a score => 3 positive PANSS (last month) and treated in one of the participating institutions. The evaluation was performed at baseline, at post-treatment and at 6 months follow up. Symptoms, metacognition, psychosocial and neuropsychological functioning were assessed.

The EMC consists of 10 therapeutic units with weekly sessions of 45-60 minutes. The material available for the Individualized Metacognitive Training (EMC) program is made up of power-point presentations. ;

Related Conditions & MeSH terms

• Brief Psychotic Disorder
• Mental Disorders
• Psychosis; Episode
• Psychotic Disorders

• NCT number: NCT04429412
• Study type: Interventional
• Source: Fundació Sant Joan de Déu
• Status: Completed
• Phase: N/A
• Start date: January 1, 2015
• Completion date: September 1, 2018